Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shen-Gu granule for glucocorticoid-induced osteoporosis
ChiCTR2000031606Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Mar 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of shen-gu granule in glucocorticoid-induced osteoporosis (GIOP), sponsored by Tongji Hospital. Primary endpoints: Signs and symptoms related to traditional Chinese medicine, Dual-energy X-ray bone mineral density measurement (DXA) and 1 more. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
shen-gu granule
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on ChiCTR2000031606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031606.